Children and adolescents with Tourette's sought for research study


15782

A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-weekly Oral Aripiprazole in Children and Adolescents with Tourette's Disorder

Psychiatry and Neurobehavioral Sciences

Madaan Vishal,

UVa Health System, Department of Psychiatry and Neurobehavioral Sciences Child & Family Psychiatry Clinic seeks children & adolescents ages 7 to 17 with Tourette’s Disorder for a research study. The purpose of this study is to learn more about using a study medication called Aripiprazole and see if the study medication is safe and helpful for children and teenagers diagnosed with Tourette’s. The study involves blood draws, an EKG, height and weight measurement, and taking an experimental medicine/placebo every day for 8 weeks. There will be 11 visits over a period of 3.5 months with a study doctor, each visit lasting an hour. o Study-related exams, tests and study medication will be provided free of change. o Compensation for study completion is $550. o There is no cost for participating in this study. Contact Information: For more information please contact: o Lea Gayle o (434) 243-3678, lcg7x@virginia.edu o IRB HSR # 15782 Principal Investigator: Dr. Vishal Madaan


Child

Tourette's Disorder

Neurology
Pediatrics
Psychiatry/Psychology

Ill

No Compensation

Leigh Gayle

lcg7x@hscmail.mcc.virginia.edu

4342433678